This is a non-core endpoint: only basic statistics are computed.
Melanoma of uvea
CD2_UVEAMELANOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
364 |
4. Check minimum number of eventsNone |
364 |
5. Include endpointsNone |
364 |
6. Filter based on genotype QC (FinnGen only) |
354 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF6
Similar endpoints
↥List of similar endpoints to
Melanoma of uvea
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of eye and adnexa, including Hilmo
- Malignant melanoma
- Malignant melanoma, including Hilmo
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 354 | 165 | 189 |
| Unadjusted period prevalence (%) | 0.07 | 0.06 | 0.09 |
| Median age at first event (years) | 64.22 | 62.08 | 66.08 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 364
- Matched controls
- 3640
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
307.7
308
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
176.4
307.7
245
42
WX140
NOMESCO Finland
Parabulbar anesthesy
45.5
296.7
210
106
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
265.2
221
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
263.8
220
*
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
203.9
176
*
XCK10
NOMESCO Finland
Photography of fundus of eye
19.7
190.5
207
228
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
70.2
176.1
98
19
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
467.7
171.7
159
6
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
15.4
153.1
182
222
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
14.7
138.9
160
184
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
18.5
138.6
129
105
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
102.0
93
*
Z3229
NOMESCO Finland
Other healthcare associate professional
10.2
92.8
131
190
XCW99
NOMESCO Finland
Other investigative procedure of eye
9.2
89.5
142
236
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
81.4
75
*
WX002
NOMESCO Finland
Sedation and analgesia
6.8
74.7
184
473
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
65.6
61
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
15.4
64.6
60
46
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
62.3
58
*
Z2221
NOMESCO Finland
Medical doctor
5.1
53.4
193
657
ZXD10
NOMESCO Finland
Scheduled procedure
5.3
51.8
246
1032
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
80.6
49.7
55
8
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
17.4
45.8
39
25
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
7.5
41.3
66
105
S01ED51
ATC
timolol, combinations; ophthalmic
5.8
40.2
86
183
ZXA05
NOMESCO Finland
Left side
4.2
40.1
178
677
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
37.1
35
*
ZXE00
NOMESCO Finland
One hour or less
3.8
34.3
216
1015
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
11.6
32.7
35
33
ZXE10
NOMESCO Finland
More than one and less than three hours
3.6
31.8
206
972
ZXA00
NOMESCO Finland
Right side
3.5
30.1
173
751
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.7
27.9
118
418
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
26.4
25
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.8
24.2
40
65
CH2S4
NOMESCO Finland
Photography of iris
256.2
23.9
24
*
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
23.3
23.9
34
16
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
23.2
22
*
130
Kela drug reimbursment
Malignant tumour
4.0
22.8
74
216
XCD20
NOMESCO Finland
Photoangiography of eye
9.0
21.3
27
32
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
21.0
20
*
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
222.2
20.8
21
*
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
211.0
19.8
20
*
S01EC01
ATC
acetazolamide; systemic
7.2
19.4
30
45
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
18.9
18
*
Z51.5
ICD-10 Finland
Palliative care
3.8
17.9
61
183
C69.45
ICD-10 Finland
Melanoma of iris
+∞
17.9
17
*
CF2S4
NOMESCO Finland
Photography of conjunctiva
100.0
17.7
19
*
WX142
NOMESCO Finland
Sub-tenon anesthesy
30.6
17.6
23
8
N02AA05
ATC
oxycodone; systemic
2.8
17.0
114
511
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
13.8
15.9
27
21
S01ED01
ATC
timolol; ophthalmic
5.2
15.8
34
71
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
+∞
15.7
15
*
CDC00
NOMESCO Finland
Enucleation of eye
166.9
15.6
16
*
D31.4
ICD-10 Finland
Benign neoplasm: Ciliary body
166.9
15.6
16
*
H26.2
ICD-10 Finland
Complicated cataract
18.8
15.4
23
13
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
15.0
214
1352
CD2S4
NOMESCO Finland
Photography of eye
26.3
14.8
20
8
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
83.6
14.7
16
*
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
14.7
14
*
3779
FHL
Other operations in this group include disc removal
156.0
14.6
15
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.4
14.3
195
1198
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
+∞
13.6
13
*
Z3231
NOMESCO Finland
Registered nurse
2.4
13.1
133
714
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
4.0
12.9
38
102
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
+∞
12.6
12
*
A04AA02
ATC
granisetron; systemic, transdermal
3.8
12.2
40
116
CA1ME
NOMESCO Finland
Ultrasound oculometry
22.2
12.1
17
8
JN4CD
NOMESCO Finland
Very extensive body CT
4.4
12.0
31
75
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.5
11.5
29
69
H43.1
ICD-10 Finland
Vitreous haemorrhage
5.6
11.5
22
41
L01AX03
ATC
temozolomide; systemic
20.8
11.2
16
8
S01EA05
ATC
brimonidine; ophthalmic
5.4
10.9
22
43
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
29.0
10.8
14
5
H02AB02
ATC
dexamethasone; systemic
2.8
10.8
62
252
C79.41
ICD-10 Finland
Secondary malignant tumor of optic nerve and eye
+∞
10.5
10
*
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
+∞
10.5
10
*
S01EA03
ATC
apraclonidine; ophthalmic
13.6
10.3
17
13
JN4BD
NOMESCO Finland
Extensive body CT
2.7
10.2
62
259
XCH00
NOMESCO Finland
Eye pressure measurement
3.7
10.2
33
95
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
15.1
10.1
16
11
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
10.0
114
632
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.8
9.9
31
87
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
20.7
9.9
14
7
H33.2
ICD-10 Finland
Serous retinal detachment
20.7
9.9
14
7
A03FA01
ATC
metoclopramide; systemic, rectal
2.2
9.8
103
552
ZXA10
NOMESCO Finland
Bilateral
2.2
9.6
94
488
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
9.6
63
274
D31.2
ICD-10 Finland
Benign neoplasm: Retina
102.6
9.5
10
*
JJ1AQ
NOMESCO Finland
Liver SPECT with low dose CT
+∞
9.4
9
*
180
Kela drug reimbursment
Interferon alfa
19.2
9.0
13
7
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.1
8.7
24
61
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
8.4
8
*
C69.20
ICD-10 Finland
Retina
+∞
8.4
8
*
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.3
8.1
65
309
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
3.9
7.8
23
62
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
46.0
7.7
9
*
A04AA01
ATC
ondansetron; systemic, rectal
2.7
7.7
43
172
S01EE01
ATC
latanoprost; ophthalmic
2.8
7.5
39
150
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.1
7.4
77
407
C69.49
ICD-10 Finland
Malignant tumor of ciliary body other or unspecified histology
+∞
7.3
7
*
C69.90
ICD-10 Finland
Malignant tumor in unspecified localization in eye without histology
+∞
7.3
7
*
Z2446
NOMESCO Finland
Social worker
2.9
6.9
33
121
RS222, ,
NOMESCO Finland
9.6
6.8
13
14
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.5
6.7
23
69
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
6.6
36
142
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
10.3
6.6
12
12
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
71.0
6.4
7
*
C69.4
ICD-10 Finland
Malignant neoplasm: Ciliary body
+∞
6.3
6
*
QX2AN
NOMESCO Finland
Other soft tissue tumour isotope imaging
+∞
6.3
6
*
CH3S4
NOMESCO Finland
Photography of iridocorneal angle
+∞
6.3
6
*
XCK00
NOMESCO Finland
Perimetry
2.7
6.2
33
128
H53.2
ICD-10 Finland
Diplopia
3.7
6.1
19
53
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
250
951
6.20
62.86
5.5
3.4
29.02
33.08
u/l
1.39
243
907
18
0
+∞
18.91
1.1
0.0
—
—
—
0
0
14
0
+∞
14.68
1.0
0.0
8.86
—
%
—
14
0
14
0
+∞
14.68
1.1
0.0
35.56
—
%
—
14
0
301
2315
2.73
12.35
13.9
7.7
89.28
79.45
u/l
1.47
290
2157
224
1618
2.00
9.20
10.1
6.5
13.46
11.38
umol/l
0.93
218
1531
221
1704
1.76
6.26
13.2
9.0
4.12
4.15
e9/l
0.06
197
1503
19
54
3.66
5.96
4.5
3.2
53.11
57.61
%
0.49
19
54
201
1525
1.71
5.88
8.6
7.0
1.21
1.21
mmol/l
0.20
165
1298
18
51
3.66
5.68
3.6
2.5
4.15
4.65
e9/l
0.29
18
51
181
1350
1.68
5.53
6.8
4.9
34.16
35.13
g/l
1.32
166
1257
184
1398
1.64
5.09
7.4
6.5
1.21
1.21
mmol/l
0.03
171
1272
63
362
1.90
4.69
3.6
4.3
8.82
37.49
ug/l
0.71
50
304
33
150
2.32
4.53
2.5
3.1
18.43
1054.27
u/ml
0.58
28
127
136
980
1.62
4.52
3.0
2.6
53.61
61.37
u/l
0.88
127
902
14
33
4.37
4.37
1.2
1.4
—
—
—
0
0
193
1536
1.55
4.05
11.6
16.1
1.20
1.30
inr
0.77
63
456
220
1807
1.55
3.97
5.8
5.4
6.95
6.83
mmol/l
0.35
209
1693
139
1034
1.56
3.93
6.6
3.3
2.35
2.35
mmol/l
0.14
122
916
19
72
2.73
3.79
1.1
1.4
—
—
—
0
0
6
5
12.17
3.77
5.0
1.8
53.33
34.60
u/l
—
6
5
21
85
2.56
3.70
2.8
2.7
1.85
1.63
mg/l
0.43
21
75
8
14
5.81
3.36
4.6
3.9
208.75
228.43
u/l
—
8
14
244
2735
0.67
3.04
6.1
6.3
41.09
40.76
mmol/mol
0.21
226
2541
167
1371
1.40
2.59
2.7
2.7
—
—
—
0
0
266
2905
0.69
2.50
4.9
5.3
2.63
2.67
mmol/l
0.27
248
2650
256
2807
0.70
2.35
4.4
4.7
1.41
1.46
mmol/l
0.97
240
2557
58
397
1.55
2.28
6.8
5.5
1.13
1.03
mmol/l
1.27
51
368
248
2729
0.71
2.27
3.9
4.2
1.38
1.28
mmol/l
1.26
232
2479
8
195
0.40
2.25
1.4
1.8
—
—
—
0
0
50
337
1.56
2.11
3.4
3.6
—
—
—
0
0
260
2829
0.72
2.11
4.5
4.8
4.49
4.55
mmol/l
0.42
242
2604
21
121
1.78
1.62
8.0
3.7
25.85
25.09
mmol/l
0.25
21
113
8
32
2.53
1.60
1.1
1.2
—
—
—
0
0
38
260
1.52
1.53
2.2
3.0
265.84
203.85
ng/l
0.29
32
232
0
42
0.00
1.53
0.0
1.1
—
1.25
—
0
12
0
43
0.00
1.53
0.0
1.0
—
—
—
0
0
0
45
0.00
1.51
0.0
1.1
—
4.00
—
0
19
13
65
2.04
1.50
1.7
3.5
41.77
34.91
umol/l
0.63
13
56
306
2882
1.39
1.49
22.1
16.2
27.28
24.88
mg/l
0.55
263
2307
268
2852
0.77
1.35
5.0
4.9
6.14
6.07
mmol/l
0.34
244
2583
9
42
2.17
1.34
1.2
1.8
—
—
—
0
0
49
364
1.40
1.32
4.4
3.1
13.14
7.92
umol/l
0.49
40
323
59
453
1.36
1.31
3.2
2.4
20.83
22.10
%
0.40
51
396
320
3051
1.40
1.31
17.6
11.1
27.94
25.95
u/l
1.23
310
2938
18
107
1.72
1.28
4.6
2.9
1.54
0.67
g/l
0.50
13
93
29
196
1.52
1.26
6.7
3.3
2.45
2.01
mmol/l
0.14
22
140
88
725
1.28
1.20
2.6
2.4
—
—
—
0
0
63
787
0.76
1.19
1.9
1.6
20.52
20.71
nmol/l
0.04
57
656
18
110
1.67
1.17
2.1
2.8
—
—
—
0
0
7
30
2.36
1.13
1.7
1.3
179.14
324.78
u/l
—
7
30
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
17
105
1.65
1.08
5.4
4.2
55.37
128.97
mg/l
—
9
82
17
105
1.65
1.08
5.4
4.2
16.00
35.93
mg/l
—
9
82
7
35
2.02
1.00
1.6
3.1
3.51
4.48
nmol/l
—
7
35
197
1800
1.21
1.00
4.2
3.4
87.02
51.41
u/l
1.90
184
1667
14
84
1.69
0.99
1.8
1.6
—
—
—
0
0
5
23
2.19
0.98
1.0
1.0
—
—
—
0
0
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
132
1163
1.21
0.98
4.1
3.3
—
—
—
0
0
105
906
1.22
0.95
3.5
3.2
0.60
0.49
e6/l
0.10
89
689
0
32
0.00
0.95
0.0
2.1
—
—
—
0
0
162
1459
1.20
0.95
3.6
4.2
0.00
0.00
estimate
0.50
41
301
35
262
1.37
0.94
1.6
1.9
1.95
1.59
%
0.65
28
226
65
784
0.79
0.93
1.8
1.7
1.53
1.33
mmol/l
0.75
59
641
84
980
0.81
0.89
5.0
4.4
21.50
21.45
%
0.01
46
482
6
30
2.02
0.87
1.5
2.9
—
—
—
0
0
74
624
1.23
0.84
4.2
4.1
561.81
239.79
ng/l
0.34
63
514
73
617
1.23
0.81
5.4
2.9
2.48
2.46
mmol/l
0.84
61
540
0
24
0.00
0.79
0.0
1.0
—
40.41
—
0
13
0
24
0.00
0.79
0.0
1.0
—
543.79
—
0
14
26
192
1.38
0.77
1.6
1.5
—
—
—
0
0
93
810
1.20
0.77
3.2
2.9
4979.77
9040.17
umol/l
0.37
78
690
9
53
1.72
0.76
1.0
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
100
1.52
0.74
3.1
2.6
0.31
0.40
u/ml
—
9
51
116
1292
0.85
0.73
2.3
2.0
98.67
94.92
pmol/l
0.30
63
670
9
59
1.54
0.69
1.2
1.4
—
—
—
0
0
14
95
1.49
0.65
1.4
1.3
—
—
—
0
0
36
442
0.79
0.62
1.2
1.3
39.76
9.16
u/ml
0.72
13
165
139
1509
0.87
0.60
2.3
2.5
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
1.13
—
0
13
0
21
0.00
0.60
0.0
1.3
—
170.75
—
0
21
0
21
0.00
0.60
0.0
2.0
—
—
—
0
0
38
461
0.80
0.60
1.2
1.3
65.63
34.32
iu/ml
0.70
16
158
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
5
86
0.58
0.57
1.2
1.2
—
—
—
0
0
15
107
1.42
0.56
1.9
1.7
—
—
—
0
0
62
711
0.85
0.55
3.5
3.0
0.74
0.81
ug/l
0.35
45
471
31
379
0.80
0.53
8.1
8.2
—
—
—
0
0
60
522
1.18
0.52
1.8
1.9
—
—
—
0
0
24
189
1.29
0.51
6.5
7.9
23.48
24.63
mmol/l
0.76
24
189
10
142
0.70
0.47
1.6
1.6
—
—
—
0
0
7
48
1.47
0.47
1.3
1.9
—
—
—
0
0
15
112
1.35
0.45
2.5
1.9
—
—
—
0
0
36
303
1.21
0.45
2.8
3.7
1.35
2.10
mmol/l
0.84
31
253
253
2618
0.89
0.44
5.3
4.6
1.90
1.98
mu/l
0.49
232
2347
9
131
0.68
0.44
1.6
1.6
—
—
—
0
0
43
371
1.18
0.42
7.7
9.2
5.18
5.13
kpa
0.10
38
358
0
15
0.00
0.41
0.0
3.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
3.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
5
34
1.48
0.40
3.2
3.9
262.00
342.66
umol/l
—
5
29
43
373
1.17
0.40
7.6
9.2
1.69
1.35
mmol/l
0.24
33
305
5
35
1.43
0.39
2.8
2.7
—
—
—
0
0
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
211
2195
0.91
0.38
4.8
4.1
16.02
13.28
mm/h
1.23
197
2004
88
810
1.11
0.36
3.5
4.5
0.00
0.01
estimate
0.50
34
273
9
123
0.72
0.36
1.4
1.3
—
—
—
0
0
25
296
0.83
0.34
8.8
7.4
1.53
1.39
mmol/l
0.23
25
290
58
523
1.13
0.33
3.0
3.0
0.76
2.31
e6/l
2.96
34
297
70
640
1.12
0.32
1.8
1.7
1244.36
1229.21
nmol/l
0.05
61
494
16
128
1.26
0.32
2.2
2.4
—
—
—
0
0
35
305
1.16
0.32
2.6
3.7
5.61
5.75
kpa
0.39
35
297
12
92
1.31
0.32
1.4
1.9
—
132.00
—
0
5
154
1466
1.09
0.31
4.9
5.5
0.00
0.00
estimate
-0.00
37
278
7
53
1.33
0.31
1.3
1.3
—
—
—
0
0
7
53
1.33
0.31
1.3
1.3
—
—
—
0
0
308
3024
1.12
0.30
24.2
19.1
139.67
139.67
mmol/l
0.00
301
2941
309
3035
1.12
0.30
24.2
19.2
4.02
4.00
mmol/l
0.75
300
2953
155
1482
1.08
0.28
3.7
4.1
0.00
0.00
estimate
-0.00
39
265
135
1284
1.08
0.28
4.1
4.1
32.90
44.03
ng/l
0.74
103
966
27
234
1.17
0.27
2.3
1.7
—
—
—
0
0
6
85
0.70
0.24
1.2
1.2
—
—
—
0
0
90
954
0.92
0.24
2.3
2.1
232.40
205.38
u/l
0.12
83
891
5
38
1.32
0.23
1.4
2.0
—
—
—
0
0
64
686
0.92
0.22
1.6
1.8
507.89
441.29
pmol/l
0.83
55
568
5
42
1.19
0.21
1.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.9
—
61.42
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
9.57
—
0
12
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
404.50
—
0
6
71
669
1.08
0.19
1.8
1.7
1.33
1.37
mg/l
0.06
59
526
5
67
0.74
0.17
1.0
1.5
—
—
—
0
0
119
1147
1.06
0.16
3.7
4.4
—
—
—
0
0
317
3137
1.08
0.16
31.2
23.7
39.59
39.84
%
0.28
290
2933
317
3138
1.08
0.15
31.0
23.5
242.55
242.31
e9/l
0.02
308
3058
6
79
0.76
0.15
1.5
1.7
—
—
—
0
0
10
119
0.84
0.15
2.6
2.3
2068.60
360.12
ug/l
—
10
111
9
78
1.16
0.15
1.9
1.5
—
—
—
0
0
317
3139
1.08
0.15
31.0
23.5
4.41
4.45
e12/l
0.71
308
3047
82
784
1.06
0.15
2.4
2.1
3.17
3.24
mg/l
0.08
76
675
317
3140
1.07
0.14
31.2
23.7
132.12
134.55
g/l
2.02
312
3085
29
266
1.10
0.14
2.1
3.0
4.43
4.39
kpa
0.04
29
257
40
376
1.07
0.12
1.4
1.8
—
—
—
0
0
10
86
1.17
0.11
1.6
1.4
—
—
—
0
0
105
1020
1.04
0.10
3.5
3.3
1129.93
1477.79
ng/l
0.91
96
879
18
197
0.91
0.10
1.4
1.6
—
—
—
0
0
40
379
1.06
0.10
1.3
1.9
—
—
—
0
0
5
44
1.14
0.10
1.0
1.5
—
—
—
0
0
5
44
1.14
0.10
1.0
1.5
—
—
—
0
0
5
44
1.14
0.10
1.0
1.5
—
—
—
0
0
5
44
1.14
0.10
1.0
1.5
—
—
—
0
0
5
45
1.11
0.10
1.0
1.4
—
—
—
0
0
39
371
1.06
0.08
4.9
4.7
32.30
31.83
%
0.09
30
248
16
146
1.10
0.08
1.2
1.2
58.50
166.48
iu/ml
—
6
52
7
65
1.08
0.08
1.1
1.2
—
—
—
0
0
27
254
1.07
0.08
2.7
3.0
46.80
60.61
ml/min/173m2
—
10
119
102
1000
1.03
0.06
4.2
3.8
18.13
9.60
mg/mmol
0.75
74
636
34
352
0.96
0.04
1.2
1.4
—
—
—
0
0
30
311
0.96
0.04
1.4
1.4
—
—
—
0
0
212
2135
0.98
0.03
4.4
3.7
15.00
14.90
pmol/l
0.22
192
1892
123
1216
1.02
0.03
2.4
2.2
76.75
77.11
nmol/l
0.05
109
1072
55
562
0.97
0.03
3.1
2.7
0.98
1.05
e6/l
0.06
32
328
273
2742
0.98
0.03
20.7
15.2
75.10
76.30
ml/min/173m2
0.39
233
2275
16
153
1.05
0.01
1.2
1.3
—
33.94
—
0
11
56
568
0.98
0.01
1.2
1.2
0.40
1.35
u/ml
—
10
152
14
146
0.96
0.00
1.1
1.2
57.39
142.84
u/ml
1.81
14
138
12
119
1.01
0.00
1.0
1.0
—
—
—
0
0
121
1206
1.00
0.00
5.5
5.1
4.74
2.71
ug/l
0.51
106
1065
66
657
1.01
0.00
3.3
4.7
1.02
1.02
kg/l
0.06
11
103
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.9
—
1.23
—
0
9
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
44.80
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
87
0.92
-0.00
5.1
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
-0.00
0.0
1.0
—
137.00
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
7
70
1.00
-0.00
1.0
1.4
—
—
—
0
0
5
57
0.88
-0.00
1.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.1
—
—
—
0
0
8
79
1.01
-0.00
1.4
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
5
57
0.88
-0.00
1.6
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_UVEAMELANOMA – Melanoma of uvea
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).